Antileishmanial agent-29
Antileishmanial agent-29 (Compound 110) is an orally active antileishmanial agent. Antileishmanial agent-29 (p.o., 40, 60 mg/kg, 10 days) protects mice from leishmania infection[1].
Product Specifications
CAS Number
9007-83-4
UNSPSC
12352005
Target
Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/antileishmanial-agent-29.html
Solubility
10 mM in DMSO
Smiles
CCC1=CC=C(C2=N/C(C(C)=C2C)=C/NC3CCCCCC3)N1
Molecular Formula
C20H29N3
Molecular Weight
311.46
References & Citations
[1]Kancharla P, et al. Discovery and Optimization of Tambjamines as a Novel Class of Antileishmanial Agents. J Med Chem. 2024 May 9.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
SPD-C5221-1mg 1 mg
SARS-CoV-2 Spike RBD Protein (R346K, E484K, N501Y), His Tag (MALS verified)
Sign In for Pricing
View Details 
LY400895 100 µg
NFkB p100 / p52 (NFKB2) (NM_002502) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC741620-500 1x 500 µL
CD10 (Membrane Metalloendopeptidase) (MME/1620), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 